These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28539827)

  • 1. Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats.
    Wang H; Zhang X; Yu P; Zhou Q; Zhang J; Zhang H; Zhu H; Zhang C; Yao W; Che L; Xu J; Bei Y; Li X
    Int J Med Sci; 2017; 14(5):506-514. PubMed ID: 28539827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase.
    Liu W; Chen J; Xu T; Tian W; Li Y; Zhang Z; Li W
    Am J Hypertens; 2012 Feb; 25(2):250-60. PubMed ID: 22089109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ.
    Shen S; Jiang H; Bei Y; Zhang J; Zhang H; Zhu H; Zhang C; Yao W; Wei C; Shang H; Li X
    Cell Physiol Biochem; 2017; 42(3):876-888. PubMed ID: 28647730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice.
    Tao L; Shen S; Fu S; Fang H; Wang X; Das S; Sluijter JP; Rosenzweig A; Zhou Y; Kong X; Xiao J; Li X
    Sci Rep; 2015 Feb; 5():8374. PubMed ID: 25669146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Chinese medicine Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy via upregulating PPARγ and PGC-1α.
    Gao RR; Wu XD; Jiang HM; Zhu YJ; Zhou YL; Zhang HF; Yao WM; Li YQ; Li XL
    Ann Transl Med; 2018 Apr; 6(8):153. PubMed ID: 29862242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Metabolic Effects of Traditional Chinese Medication Qiliqiangxin on H9C2 Cardiomyocytes.
    Lin S; Wu X; Tao L; Bei Y; Zhang H; Zhou Y; Shen S; Xiao J; Li X
    Cell Physiol Biochem; 2015; 37(6):2246-56. PubMed ID: 26618786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
    Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H
    Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway.
    Chen Y; Chang Y; Zhang N; Guo X; Sun G; Sun Y
    Cell Physiol Biochem; 2018; 46(3):1009-1018. PubMed ID: 29669326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qiliqiangxin reduced cardiomyocytes apotosis and improved heart function in infarcted heart through Pink1/Parkin -mediated mitochondrial autophagy.
    Zhou J; Wang Z; He Y; Luo X; Zhang W; Yu L; Chen X; He X; Yuan Y; Wang X; Guo X; Tang J; Zhu M; Li D; Ding Y
    BMC Complement Med Ther; 2020 Jul; 20(1):203. PubMed ID: 32615967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
    Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
    Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ.
    Wu X; Zhang T; Lyu P; Chen M; Ni G; Cheng H; Xu G; Li X; Wang L; Shang H
    Front Cardiovasc Med; 2021; 8():698056. PubMed ID: 34336956
    [No Abstract]   [Full Text] [Related]  

  • 12. Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?
    Packer M
    Eur J Heart Fail; 2023 Dec; 25(12):2130-2143. PubMed ID: 37877337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qili Qiangxin capsule attenuates myocardial fibrosis by modulating collagen homeostasis post-infarction in rats.
    Sun M; Liu C; Gao K; Xu X; Chen K; Qiu L; Wang X
    PLoS One; 2024; 19(9):e0310897. PubMed ID: 39331597
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Cheng H; Wu X; Ni G; Wang S; Peng W; Zhang H; Gao J; Li X
    Ann Transl Med; 2020 Nov; 8(21):1396. PubMed ID: 33313141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qingda granules attenuate hypertensive cardiac remodeling and inflammation in spontaneously hypertensive rats.
    Wu X; Shen A; Bao L; Wu M; Lin X; Wang H; Chen Y; Cai Q; Lin S; Zhou X; Lu Y; Peng M; Chen D; Chu J; Peng J
    Biomed Pharmacother; 2020 Sep; 129():110367. PubMed ID: 32559624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tong-xin-luo capsule inhibits left ventricular remodeling in spontaneously hypertensive rats by enhancing PPAR-gamma expression and suppressing NF-kappaB activity.
    Bu PL; Zhao XQ; Wang LL; Zhao YX; Li CB; Zhang Y
    Chin Med J (Engl); 2008 Jan; 121(2):147-54. PubMed ID: 18272042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin reverses cardiac remodeling possibly through regulation of protein kinase D/myocyte enhancer factor 2D activation in spontaneously hypertensive rats.
    Geng J; Zhao Z; Kang W; Wang W; Zhang Y; Zhiming GE
    Pharmacol Res; 2010 Jan; 61(1):40-7. PubMed ID: 19683055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qiliqiangxin prevents right ventricular remodeling by inhibiting apoptosis and improving metabolism reprogramming with pulmonary arterial hypertension.
    Lu Y; Wu J; Sun Y; Xin L; Jiang Z; Lin H; Zhao M; Cui X
    Am J Transl Res; 2020; 12(9):5655-5669. PubMed ID: 33042446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on Q-markers of Qiliqiangxin capsule for chronic heart failure treatment based on pharmacokinetics and pharmacodynamics association.
    Zhang F; Zhang Y; Li X; Zhang S; Zhu M; Du W; Xiao X
    Phytomedicine; 2018 May; 44():220-230. PubMed ID: 29699844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.
    Zhang WB; Du QJ; Li H; Sun AJ; Qiu ZH; Wu CN; Zhao G; Gong H; Hu K; Zou YZ; Ge JB
    J Cell Mol Med; 2012 Sep; 16(9):2227-37. PubMed ID: 22288611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.